TTANGO2: Uptake, sustainability and impact of scaling up point-of-care testing for sexually transmissible infections in remote and regional Aboriginal communitiesUptake, sustainability and impact of scaling up point-of-care testing for sexually transmissible infections in remote and regional Aboriginal communities

  • Guy, Rebecca (Chief Investigator (Project Lead))
  • Shephard, Mark (Chief Investigator (Flinders Lead))
  • Armstrong, Paul (Chief Investigator)
  • Atkinson, David (Chief Investigator)
  • Fairley, Christopher (Chief Investigator)
  • Kaldor, John (Chief Investigator)
  • Mak, Donna (Chief Investigator)
  • Persing, David (Chief Investigator)
  • Speers, David (Chief Investigator)
  • Ward, James (Chief Investigator)
  • Matthews, Susan (Chief Investigator)

    Project Details

    Description

    Aboriginal youth experience unacceptably high rates of curable sexually transmissible infections (STI). Coverage of testing and treatment is insufficient for disease control but could be enhanced via point-of-care (POC) testing. We have been trialling a highly accurate STI/POC diagnostic in the TTANGO (Test, Treat ANd GO) trial. The TTANGO2 partnership will assess the long-term uptake, sustainability and impact of POC testing in 20 Aboriginal health services in regional/remote WA over 5 years.
    StatusFinished
    Effective start/end date1/01/151/01/20

    Funding

    • National Health and Medical Research Council: A$1,406,911.25
    • National Health and Medical Research Council: A$553,000.00
    • University of New South Wales: A$97,000.00
    • University of New South Wales: A$126,901.00

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.